Blog
RSS FeedPosted by Michael Wonder on 09 Feb 2021
Scotland approves MS drug that was rejected in England and Wales
9 February 2021 - A drug that can reduce the number of relapses suffered by people with multiple sclerosis has been ...
Posted by Michael Wonder on 08 Feb 2021
SMC - February 2021 decisions
8 February 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 20 Jan 2021
Scottish Health Technologies Group: enhancing patient engagement
20 January 2021 - The Scottish Health Technologies Group provides evidence support and advice to the National Health Service in Scotland ...
Posted by Michael Wonder on 20 Jan 2021
Scotland backs Roche’s Rozlytrek for ROS1 lung cancer
19 January 2021 - The Scottish Medicines Consortium has given a green light to Roche’s Rozlytrek for a rare form ...
Posted by Michael Wonder on 18 Jan 2021
SMC - January 2021 decisions
18 January 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice ...
Posted by Michael Wonder on 11 Jan 2021
SMC to support innovative new medicines pathway
29 December 2020 - Experts from the Scottish Medicines Consortium are to support a new licensing and access pathway which ...
Posted by Michael Wonder on 07 Dec 2020
SMC - December 2020 decisions
7 December 2020 - Medicines which can be used to treat a form of blood cancer and a rare muscle ...
Posted by Michael Wonder on 12 Nov 2020
After NICE okay, Scots denied access to Vifor’s Veltassa
10 November 2020 - The SMC has ruled that there’s not enough evidence to support NHS funding of Vifor Pharma’s ...
Posted by Michael Wonder on 09 Nov 2020
New osteoporosis drug for women approved for use on NHS in Scotland
9 October 2020 - A new drug to treat women with severe cases of the bone disease osteoporosis has been ...
Posted by Michael Wonder on 09 Nov 2020
SMC - November 2020 decisions
9 November 2020 - Advice on eight new medicines for use in conditions including breast cancer, lung cancer and osteoporosis has ...
Posted by Michael Wonder on 14 Oct 2020
Scotland backs two myeloma drugs turned down by NICE in England
14 October 2020 - A north-south divide threatens to emerge in multiple myeloma in the UK, after the Scottish Medicines ...
Posted by Michael Wonder on 12 Oct 2020
SMC accepts Bavencio (avelumab) in combination with axitinib for the first-line treatment of adult patients with advanced or metastatic renal cell carcinoma
12 October 2020 - Merck and Pfizer announced today that the Scottish Medicines Consortium has accepted the immunotherapy Bavencio (avelumab) for ...
Posted by Michael Wonder on 12 Oct 2020
SMC - October 2020 decisions
12 October 2020 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has today ...
Posted by Michael Wonder on 06 Oct 2020
Update on SMC remobilisation
2 October 2020 - SMC business recovery following the early stages of the COVID-19 pandemic continues to progress well. ...
Posted by Michael Wonder on 23 Sep 2020
SMC plays key role in helping to secure access to COVID-19 treatments
15 September 2020 - The Scottish Medicines Consortium is part of a UK-wide multi-agency initiative to secure access to potential ...